Urology/Oncology

A guide specifically aimed at the partners and caregivers of men diagnosed with prostate cancer, offering expert advice, insights, and support to help them navigate the patient's care journey.

Official guidelines from the European Association of Urology (EAU) providing detailed recommendations on the epidemiology, staging (TNM 2017), and grading (WHO classifications) of non-muscle-invasive bladder cancer (TaT1, CIS). It covers definitions and classification of specific tumor types, including Carcinoma in situ.

Provides a comprehensive review of diagnosis and treatments of renal cell carcinoma (RCC) for practitioners and researchers. It covers topics from basic biology and pathology to clinical practice, including etiology, diagnosis, and all treatment options. The book makes a strong effort to catch up with the key, most up-to-date advances in information about molecular bases and targeted therapy of this neoplasm.

A guide designed for patients and their loved ones who have been diagnosed with a prostate-related disease or cancer, aimed at simplifying complex medical information.

An editorial review summarizing the transformative advancements in prostate cancer (PCa) and prostatic diseases during 2024. Topics covered include progress in basic science, diagnostic tools (AI-powered risk calculators, PSMA PET-CT), novel therapeutic options like focal therapy, management of biochemical recurrence (BCR), and emerging technological innovations, including robotics and minimally invasive techniques (MISTs).

This book addresses the management of subtype-specific urology cancer patients, focusing specifically on robotic surgical techniques for renal cancer. It draws attention to improving care pathways and is intended for trainee and practicing physicians in urology oncology, specialist nursing, and general practice.

This book is a reprint of articles from a Special Issue of the journal Biomedicines, focusing on recent advances in the treatment and prognosis of kidney and upper urinary tract cancers. Topics covered include real-world experience with adverse events of Cabozantinib in metastatic renal cell carcinoma (RCC), expression markers in urothelial carcinoma, molecular risk modeling (lncRNA) in clear cell RCC, and a neurosurgical perspective on brain metastases from RCC.

Comprehensive clinical guidelines published by the European Association of Urology (EAU) detailing the epidemiology, staging, diagnosis (imaging, ureteroscopy), prognosis, and management strategies, including kidney-sparing surgery, radical nephroureterectomy, and perioperative chemotherapy for Upper Urinary Tract Urothelial Carcinoma.

This practical guide addresses the management of subtype specific urology cancer patients, drawing attention to each step of their pathway with suggestions on how care can potentially be improved. It is of interest to a range of trainee and practicing physicians in disciplines including urology oncology, specialist nurses, and general practitioners.